ArticleAmerican journal of translational research2016

eIF5A2 is an alternative pathway for cell proliferation in cetuximab-treated epithelial hepatocellular carcinoma.

Fei Xue et al.PubMed ↗Full text ↗

No numbers read from the abstract.